Utter Christine Marie
SEC CIK 1707685 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | SVP, CAO, Fin | 89.9K | — | $5.51M | 29 | 2022-01-07 | 2026-06-17 |
Most active insiders at PTCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | — | $25.99M |
| 2 | Pauwels Eric | Chief BUSINESS Off | — | $7.48M |
| 3 | SCHMERTZLER MICHAEL | Dir | — | $6.31M |
| 4 | Boulding Mark Elliott | EVP AND CLO | — | $5.96M |
| 5 | Reeve Emma | Dir | — | $4.23M |
| 6 | Klein Matthew B. | CEO, Dir | — | $4.22M |
| 7 | Jacobson Allan Steven | Dir | — | $2.91M |
| 8 | Utter Christine Marie | SVP, CAO | — | $1.94M |
| 9 | Okey Stephanie | Dir | — | $1.46M |
| 10 | Smith Mary L. | Dir | — | $1.43M |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-22 17:20 | 2026-06-17 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | M - OptEx | $25.69 | +19.7K | 89.9K | +28% | +$505.7K |
| DT | 2026-06-22 17:20 | 2026-06-17 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale+OE | $75.56 | -19.7K | 70.2K | -22% | -$1.49M |
| 2026-02-20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $69.36 | -2,494 | 70.2K | -3% | -$173.0K | |
| 2026-01-12 | 2026-01-08 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $76.45 | -1,034 | 72.7K | -1% | -$79.0K | |
| M | 2026-01-08 | 2026-01-06+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $77.19 | -2,616 | 75.0K | -3% | -$201.9K |
| D | 2026-01-06 | 2026-01-02 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +13.2K | 76.3K | +21% | $0 |
| M | 2025-02-21 | 2025-02-19+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $50.11 | -1,757 | 63.4K | -3% | -$88.0K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $44.87 | -2,953 | 64.3K | -4% | -$132.5K |
| D | 2025-01-07 | 2025-01-03 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +14.0K | 67.3K | +26% | $0 |
| DM | 2024-12-04 | 2024-12-02 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale+OE | $51.77 | -17.8K | 53.0K | -25% | -$921.6K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | M - OptEx | $51.00 | +17.8K | 55.5K | +47% | +$907.8K |
| DM | 2024-02-16 | 2024-02-15 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +16.9K | 49.5K | +52% | $0 |
| 2024-02-01 | 2024-01-30 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO | S - Sale | $27.25 | -318 | 35.5K | -0.9% | -$8,666 | |
| M | 2024-01-10 | 2024-01-08+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $28.86 | -2,841 | 37.5K | -7% | -$82.0K |
| DM | 2023-04-25 | 2023-04-21 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $33.02 | +4,692 | 38.4K | +14% | +$154.9K |
| DM | 2023-04-25 | 2023-04-21 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $55.06 | -4,692 | 38.1K | -11% | -$258.3K |
| DM | 2023-03-31 | 2023-03-29 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $47.79 | -4,688 | 38.1K | -11% | -$224.1K |
| D | 2023-03-31 | 2023-03-29 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $40.45 | +4,688 | 42.7K | +12% | +$189.6K |
| DM | 2023-03-29 | 2023-03-27 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $45.10 | -26.7K | 38.3K | -41% | -$1.20M |
| DM | 2023-03-29 | 2023-03-27 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $33.02 | +26.7K | 55.0K | +94% | +$880.2K |
| 2023-02-02 | 2023-01-31 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $45.63 | -325 | 38.1K | -0.8% | -$14.8K | |
| M | 2023-01-12 | 2023-01-10+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $43.59 | -906 | 38.8K | -2% | -$39.5K |
| 2023-01-11 | 2023-01-09 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $41.66 | -706 | 39.3K | -2% | -$29.4K | |
| D | 2023-01-09 | 2023-01-05 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | A - Grant | $0.00 | +14.0K | 40.0K | +54% | $0 |
| M | 2022-02-03 | 2022-02-01+ | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $40.26 | -1,020 | 26.1K | -4% | -$41.1K |
| D | 2022-01-20 | 2022-01-18 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | M - OptEx | $18.01 | +10.0K | 36.4K | +38% | +$180.1K |
| DM | 2022-01-20 | 2022-01-18 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale+OE | $43.94 | -11.4K | 26.4K | -30% | -$502.1K |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | S - Sale | $38.53 | -747 | 16.3K | -4% | -$28.8K |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | SVP, CAO, Fin | A - Grant | $0.00 | +11.6K | 27.9K | +71% | $0 |
Purchase Sale Sale after option exercise All abbreviations